Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fairey AS et al. - Increased comorbidity was independently associated with an increased risk of overall mortality and bladder cancer specific mortality after radical cystectomy.

Related Articles

Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
World Journal of Urology, 10/26/09    Relevance Score: 89%

Upper Urinary Tract Recurrence After Radical Cystectomy for Bladder Cancer--Who is at Risk
The Journal of Urology, 11/12/09    Relevance Score: 87%

Fast Track Program in Patients Undergoing Radical Cystectomy: Results in 362 Consecutive Patients
Journal of the American College of Surgeons, 10/30/09    Relevance Score: 87%

Recurrence rate of endometrioma after laparoscopic cystectomy: A comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/22/09    Relevance Score: 87%

Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months
BJU International, 11/17/09    Relevance Score: 85%

Today in Bladder...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09

XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/04/09

Today in Oncology...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address